The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Their symptom improvement was likely thanks to their weight loss, the FDA said. Zepbound is a glucagon-like peptide 1 drug that reduces appetite and food intake. The drug's active ingredient, ...

Elected officials are looking to expand access to weight loss drugs like Ozempic and Wegovy for low-income Virginians as part ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Body mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...